UCHL1 Shields Spinal Disc Cells From Aging Via a Novel Autophagy-Ferroptosis Switch
A deubiquitinase stabilizes a key chaperone protein to activate protective autophagy and block iron-driven cell death in spinal discs.
Summary
Researchers identified UCHL1, a deubiquitinating enzyme, as a key protector against nucleus pulposus cell (NPC) senescence and intervertebral disc degeneration (IVDD). UCHL1 stabilizes the chaperone protein HSPA8 by removing ubiquitin tags that would otherwise target it for degradation. Stabilized HSPA8 then activates chaperone-mediated autophagy (CMA), which degrades HPCAL1—a protein that drives autophagy-dependent ferroptosis (iron-mediated cell death). By suppressing ferroptosis, UCHL1 reduces cellular aging markers in disc cells. Engineered exosomes delivering UCHL1-overexpressing plasmids successfully reduced NPC senescence and slowed disc degeneration in animal models, suggesting a viable therapeutic delivery strategy for chronic low back pain.
Detailed Summary
Intervertebral disc degeneration (IVDD) is a leading cause of chronic low back pain and disability worldwide, yet disease-modifying therapies remain elusive. Nucleus pulposus cells (NPCs), the load-bearing core of spinal discs, undergo progressive senescence during degeneration, but the molecular mechanisms linking protein quality control to cell aging in this context have been poorly understood.
This study used transcriptomic sequencing of human disc samples to identify UCHL1 (ubiquitin C-terminal hydrolase L1) as a downregulated factor in degenerated discs. UCHL1 is a deubiquitinating enzyme (DUB) known for its role in protein homeostasis. Investigators found that UCHL1 physically interacts with HSPA8 (also known as HSC70), the cytosolic chaperone essential for chaperone-mediated autophagy (CMA), and removes ubiquitin chains from HSPA8, preventing its proteasomal degradation. This stabilization of HSPA8 was both necessary and sufficient to activate CMA in NPCs.
Once activated, CMA-competent HSPA8 recognizes a classical 'KFERQ' pentapeptide motif on HPCAL1 (hippocalcin-like protein 1) and shuttles it to lysosomes for degradation. HPCAL1 had previously been implicated as a driver of autophagy-dependent ferroptosis—a regulated form of iron- and lipid-peroxidation-driven cell death. By clearing HPCAL1, the UCHL1→HSPA8→CMA axis effectively suppresses ferroptotic signaling, reducing reactive oxygen species (ROS), lipid peroxidation, and canonical senescence markers (SA-β-gal activity, SASP cytokines, p21/p16 upregulation) in NPCs exposed to oxidative stress (tert-butyl hydroperoxide, TBHP).
To translate these findings therapeutically, the authors engineered exosomes derived from rat bone marrow mesenchymal stem cells (RnBMSCs) to carry UCHL1-overexpressing plasmids. Intradiscal delivery of these engineered exosomes in a rat IVDD model significantly reduced NPC senescence markers and attenuated histological disc degeneration, as confirmed by Safranin O/Fast Green staining, Alcian Blue staining, and MRI grading. Adeno-associated virus (AAV)-mediated UCHL1 overexpression in vivo produced comparable benefits, reinforcing the therapeutic potential of the pathway.
Taken together, the study establishes a linear molecular cascade—UCHL1 deubiquitinates and stabilizes HSPA8 → HSPA8-driven CMA degrades HPCAL1 → HPCAL1 elimination suppresses autophagy-dependent ferroptosis → reduced NPC senescence and IVDD progression. This positions UCHL1 and CMA activation as promising targets for disc degeneration therapy and potentially for other senescence-driven degenerative conditions.
Key Findings
- UCHL1 is downregulated in degenerated human discs and its loss accelerates NPC senescence.
- UCHL1 deubiquitinates HSPA8, preventing its proteasomal degradation and thereby activating CMA.
- CMA-active HSPA8 degrades HPCAL1 via its KFERQ motif, suppressing autophagy-dependent ferroptosis.
- Engineered exosomes carrying UCHL1 plasmids reduced disc degeneration and NPC senescence in rat models.
- The UCHL1→HSPA8→CMA→HPCAL1 axis represents a novel, druggable anti-aging pathway in spinal discs.
Methodology
The study combined transcriptomic sequencing of human IVDD samples with in vitro oxidative-stress models (TBHP-treated human and rat NPCs) and in vivo rat disc degeneration models. Mechanistic dissection used co-immunoprecipitation, immunoprecipitation-mass spectrometry, cycloheximide chase assays, and CMA activity reporters. Therapeutic delivery was tested via intradiscal injection of engineered exosomes and AAV vectors overexpressing UCHL1.
Study Limitations
The in vivo data are limited to a rat needle-puncture disc degeneration model, which incompletely recapitulates human IVDD biomechanics and pathology. Long-term safety and efficacy of engineered exosome delivery have not been assessed. Causality in human tissue is inferred from expression correlation, not interventional data.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.